Growth Hormone Receptor Antagonist Markedly Improves Gemcitabine Response in a Mouse Xenograft Model of Human Pancreatic Cancer.

Autor: Basu, Reetobrata1,2,3 (AUTHOR) basu@ohio.edu, Kulkarni, Prateek1,4,5 (AUTHOR) pk585316@ohio.edu, Swegan, Deborah1,5 (AUTHOR) ds877818@ohio.edu, Duran-Ortiz, Silvana1 (AUTHOR) duranor@ohio.edu, Ahmad, Arshad1,6 (AUTHOR) aa446721@ohio.edu, Caggiano, Lydia J.1,7 (AUTHOR) lc874519@ohio.edu, Davis, Emily1,4,5 (AUTHOR) ed218514@ohio.edu, Walsh, Christopher1,3,6 (AUTHOR) cw763712@ohio.edu, Brenya, Edward1,5 (AUTHOR) eb843318@ohio.edu, Koshal, Adeel8 (AUTHOR) adeel.b.koshal@vanderbilt.edu, Brody, Rich9 (AUTHOR) rbrody@infinixbio.com, Sandbhor, Uday9 (AUTHOR) usandbhor@infinixbio.com, Neggers, Sebastian J. C. M. M.10 (AUTHOR) s.neggers@erasmusmc.nl, Kopchick, John J.1,2,3,4,5,6 (AUTHOR) kopchick@ohio.edu
Zdroj: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 13, p7438. 26p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje